• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌筛查:我们走过了哪些历程,又将走向何方?基于历史、数据和经验的个人观点。

Breast cancer screening: Where have we been and where are we going? A personal perspective based on history, data and experience.

作者信息

Kopans Daniel B

机构信息

Radiology Harvard Medical School, Founder Bresat Imagning Division Massachusetts General Hospital, 20 Manitoba Road, Waban, MA 02468, United States.

出版信息

Clin Imaging. 2018 Jul-Aug;50:91-95. doi: 10.1016/j.clinimag.2017.12.013. Epub 2017 Dec 27.

DOI:10.1016/j.clinimag.2017.12.013
PMID:29331672
Abstract

It is important to understand the history of breast cancer screening to better understand the continuing effort to reduce access to screening. Since the randomized, controlled trials have shown a statistically significant mortality reduction for women ages 40-74, the appropriate threshold for initiating screening is age 40 with no data to support the use of the age of 50 as a threshold for screening. All women are at risk for developing breast cancer and all women should have access to screening.

摘要

了解乳腺癌筛查的历史对于更好地理解为减少筛查机会所做的持续努力很重要。由于随机对照试验已显示40至74岁女性的死亡率在统计学上有显著降低,因此开始筛查的合适阈值是40岁,没有数据支持将50岁作为筛查阈值。所有女性都有患乳腺癌的风险,所有女性都应该有机会接受筛查。

相似文献

1
Breast cancer screening: Where have we been and where are we going? A personal perspective based on history, data and experience.乳腺癌筛查:我们走过了哪些历程,又将走向何方?基于历史、数据和经验的个人观点。
Clin Imaging. 2018 Jul-Aug;50:91-95. doi: 10.1016/j.clinimag.2017.12.013. Epub 2017 Dec 27.
2
Breast cancer screening: Where have we been and where are we going? A personal perspective based on history, data and experience.乳腺癌筛查:我们走过了哪些历程,又将走向何方?基于历史、数据和经验的个人观点。
Clin Imaging. 2018 Mar-Apr;48:vii-xi. doi: 10.1016/j.clinimag.2017.12.016.
3
Screening MRI in Women With a Personal History of Breast Cancer.对有乳腺癌个人病史的女性进行 MRI 筛查。
J Natl Cancer Inst. 2016 Jan 7;108(3). doi: 10.1093/jnci/djv349. Print 2016 Mar.
4
The evolution of breast imaging: past to present.乳腺影像学的发展:从过去到现在。
Radiology. 2014 Nov;273(2 Suppl):S23-44. doi: 10.1148/radiol.14141233.
5
Mammography: better, safer, and more effective?乳腺钼靶检查:更好、更安全且更有效?
Radiology. 2006 Jul;240(1):3-5. doi: 10.1148/radiol.2401051399.
6
Breast cancer screening: a 35-year perspective.乳腺癌筛查:35 年的视角。
Epidemiol Rev. 2011;33:165-75. doi: 10.1093/epirev/mxr003. Epub 2011 Jun 22.
7
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.家族性乳腺癌风险女性的磁共振成像筛查的成本效益。
J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203. Epub 2013 Aug 12.
8
[Screening of breast carcinoma screening in the Czech Republic requires cooperation with surgeons].[在捷克共和国进行乳腺癌筛查需要与外科医生合作]。
Rozhl Chir. 2012 Mar;91(3):121-31.
9
Mammography screening: A major issue in medicine.乳腺 X 光筛查:医学中的一个重大问题。
Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20.
10
Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.平均风险女性的乳腺癌筛查:美国放射学会乳腺影像委员会的建议
J Am Coll Radiol. 2017 Sep;14(9):1137-1143. doi: 10.1016/j.jacr.2017.06.001. Epub 2017 Jun 22.

引用本文的文献

1
Novel imaging approaches to screen for breast cancer: Recent advances and future prospects.新型乳腺癌筛查成像方法:最新进展与未来展望。
Med Eng Phys. 2019 Oct;72:27-37. doi: 10.1016/j.medengphy.2019.09.001.
2
Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer.白藜芦醇通过抑制上皮间质转化和调节 SIRT1/β-catenin 信号通路促进阿霉素敏感性在乳腺癌中的作用。
Cancer Med. 2019 Mar;8(3):1246-1257. doi: 10.1002/cam4.1993. Epub 2019 Jan 29.